Cargando…
DNM3, p65 and p53 from exosomes represent potential clinical diagnosis markers for glioblastoma multiforme
BACKGROUND: Glioblastoma multiforme (GBM) is the most aggressive and deadly primary brain cancer that arises from astrocytes and classified as grade IV. Recently, exosomes have been reported as an essential mediator in diverse cancer carcinogenesis and metastasis. However, their role in GBM is still...
Autores principales: | Yang, Jian-kai, Song, Jian, Huo, Hao-ran, Zhao, Yin-long, Zhang, Guang-yu, Zhao, Zong-mao, Sun, Guo-zhu, Jiao, Bao-hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808838/ https://www.ncbi.nlm.nih.gov/pubmed/29449895 http://dx.doi.org/10.1177/1758834017737471 |
Ejemplares similares
-
p53 regulates the mevalonate pathway in human glioblastoma multiforme
por: Laezza, C, et al.
Publicado: (2015) -
DNM3 Attenuates Hepatocellular Carcinoma Growth by Activating P53
por: Zhang, Zhengdong, et al.
Publicado: (2016) -
Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor
por: Costa, Barbara, et al.
Publicado: (2013) -
PD-L1 Expression Correlated with p53 Expression in Pediatric Glioblastoma Multiforme
por: Litak, Jakub, et al.
Publicado: (2021) -
Activation of p53 by Nutlin-3a Induces Apoptosis and Cellular Senescence in Human Glioblastoma Multiforme
por: Villalonga-Planells, Ruth, et al.
Publicado: (2011)